Cargando…
Repeated Autologous Bone Marrow Transfusion through Portal Vein for Treating Decompensated Liver Cirrhosis after Splenectomy
OBJECTIVE: This study is aimed at examining the impact of repeated intraportal autologous bone marrow transfusion (ABMT) in patients with decompensated liver cirrhosis after splenectomy. METHODS: A total of 25 patients with decompensated liver cirrhosis undergoing splenectomy were divided into ABMT...
Autores principales: | Zhang, Weiwei, Teng, Mujian, Liu, Baochi, Liu, Qiling, Liu, Xin, Si, Yanhui, Li, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231388/ https://www.ncbi.nlm.nih.gov/pubmed/30510572 http://dx.doi.org/10.1155/2018/4136082 |
Ejemplares similares
-
Autologous bone marrow infusion via portal vein combined with splenectomy for decompensated liver cirrhosis: A retrospective study
por: Liu, Bao-Chi, et al.
Publicado: (2023) -
Autologous Bone Marrow Cell Infusion for the Treatment of Decompensated Liver Cirrhosis Patients With Type 2 Diabetes Mellitus
por: Liu, Baochi, et al.
Publicado: (2021) -
Therapeutic effect of autologous bone marrow cells injected into the liver under the guidance of B‑ultrasound in the treatment of HBV‑related decompensated liver cirrhosis
por: Li, Lei, et al.
Publicado: (2022) -
Curative effect of hepatic portal venous administration of autologous bone marrow in AIDS patients with decompensated liver cirrhosis
por: Liu, B, et al.
Publicado: (2013) -
Elective Splenectomy Combined with Modified Hassab's or Sugiura Procedure for Portal Hypertension in Decompensated Cirrhosis
por: Zhang, Ya-wu, et al.
Publicado: (2019)